MedTrace Logo

Optimizing Lifestyles Through Increased Vegetable-rich Eating Pilot Study

NCT07509502 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-08-10

No results posted yet for this study

Summary

The goal of this pilot clinical trial is to examine how receipt of ingredients for a Mediterranean diet (with or without nutrition classes) impacts Type 2 Diabetes Mellitus risk factors among adults in the US South. The main question it aims to answer is:

\- Will greater improvements in diet quality (HEI Score) and body weight be seen in the group that receives grocery delivery and nutrition classes (TK+FiM) compared to the group receiving grocery delivery only (FiM only)?

Researchers will evaluate the changes in diet quality and body weight among participants in each group to see which group experiences greater improvements.

Participants will:

* be randomly assigned to either receive weekly grocery deliveries and attend weekly virtual nutrition classes for 4 weeks or receive weekly grocery deliveries only.
* be asked to complete surveys/questionnaires at the baseline and 4-week timepoints in the study.
* be asked to participate in a post-study focus group to talk about their experiences during the intervention.

Conditions

  • Type 2 Diabetes (T2DM)
  • Obesity & Overweight

Interventions

BEHAVIORAL

Dietary Intervention Teaching Kitchen (TK) Classes

Participants will attend virtual classes once per week for 4 weeks.

BEHAVIORAL

Food is Medicine Grocery Provision (FiM)

Participants will receive a delivery of up to $25 worth of grocery ingredients that support a Mediterranean diet each week for 4 weeks.

Sponsors & Collaborators

  • University of South Carolina

    lead OTHER

Principal Investigators

  • Brie Turner-McGrievy, PhD, MS, RD · University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-23
Primary Completion
2026-07-14
Completion
2027-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07509502 on ClinicalTrials.gov